Thus, understanding the function of SOCS2 in macorphages during NASH progression and the relationship between SOCS2, NF-κB and inflammation may attribute to understanding the mechanism of NASH pathogenesis and allow for an exploration into potential preventative and therapeutic strategies for NASH. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.